Notes

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases on 2026-09-08T21:00:29.323734+00:00, with links to news about INBRX-106, a Phase 2 HNSCC study, and financial results. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases on 2026-09-08T21:00:29.318306+00:00, with links to news about oral dabogratinib, the SURF302 Phase 2 study, and financial results. For IRD, a news release from https://ir.opusgtx.com/press-releases on 2026-09-08T21:00:29.490235+00:00, with links to news about OPGX-BEST1 cohort 1 clinical data, financial results, and a corporate update.

A news scan found the following financial news. On September 8, 2026, at 20:45:32, a scan of 200 items across 4 pages found 9 matches and omitted 5 items. The news items included: Apnimed's Q2 earnings per share was $3.91, beating the estimate of $(0.34), with sales of $12.080M. Casey's General Stores' Q1 earnings per share was $7.37, beating the estimate of $6.72, with sales of $5.678B. ServiceTitan raised its FY2027 sales guidance from $1.130B-$1.140B to $1.139B-$1.144B, compared to the estimate of $1.138B. Braze raised its FY2027 adjusted earnings per share guidance from $0.61-$0.65 to $0.64-$0.65, compared to the estimate of $0.63, and raised its FY2027 sales guidance from $884.000M-$889.000M to $910.000M-$913.000M, compared to the estimate of $898.085M. The scan covered 5 hours of bounded news discovery, required issuer verification, and did not include any orders.

A news scan found the closing summary of the INBX fund. The fund, named quant, was updated at 20:30:30 UTC on 2026-09-08. This update is for research only. The requested end time was 20:00:00 UTC on the same day. There were 329 events, and there are no more events to report. The unique identifier for this update is bed58c784032e4f3. The first event of the day occurred at 13:30:00 UTC, with a closing price of 117.53, a high of 117.53, a low of 114.0623, and a volume of 17080. The last event occurred at 19:59:00 UTC, with a closing price of 114.68, a high of 114.96, a low of 114.34, and a volume of 21868. The lowest price of the day was 94.0001, and the highest price was 120.1825. The total volume for the day was 1434084. The IEX quote at 20:00:01 UTC showed an ask price of 134.6, a bid price of 94.6, and a volume of 100. The IEX trade at 19:59:28 UTC showed a price of 114.54, a size of 100, and an identifier of 1281. The data source is https://runway.adityaperswal.workers.dev/data/stock-bars?feed=sip; stock-snapshots?feed=iex. Note that this summary is not a raw archive, and missing bars are not filled. The last minute is not an official auction, and quotes and trades are asynchronous, with no orders.

A news scan found the following headlines: for INBX, a link to the news release 'Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study' was found on 2026-09-08 at 20:30:28 UTC. For TYRA, a link to the news release 'Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR-NMIBC on September 9, 2026' was found on 2026-09-08 at 20:30:28 UTC. For IRD, a link to the press release 'Opus Genetics to Present OPGX-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences' was found on 2026-09-08 at 20:30:28 UTC.

A news scan found the closing summary of the quant fund on September 8, 2026, at 19:45:55 UTC. The fund was in research mode only. The summary started at 13:30:00 UTC and ended at 19:29:00 UTC. There were 302 events, and the volume was 1,285,668. The lowest price was 94.0001, and the highest price was 120.1825. The first event had an opening price of 117.22, a high of 117.53, a low of 114.0623, and a closing price of 117.53. The last event had an opening price of 116.82, a high of 116.82, a low of 116.79, and a closing price of 116.79. The IEX quote at 19:45:52 UTC had an ask price of 131.1 and a bid price of 97.49. The IEX trade at 19:44:40 UTC had a price of 116.33. The data source is https://runway.adityaperswal.workers.dev/data/stock-bars?feed=sip ; stock-snapshots?feed=iex. Note that the data is a summary and not raw, and some information may be missing.

A news scan found the following information for the stocks INBX, TYRA, and IRD. For INBX, the news came from https://inhibrx.investorroom.com/news-releases on 2026-09-08T19:45:36.145586+00:00, with a hash of 41195437507f, and had 3 matches and 0 omissions. The links provided were for news releases about INBRX-106, including a Phase 2 HNSCC study and financial results. For TYRA, the news came from https://tyrabio.investorroom.com/news-releases on 2026-09-08T19:45:36.163628+00:00, with a hash of c582bcc7e5dc, and had 3 matches and 0 omissions. The links provided were for news releases about Tyra Biosciences, including financial results and a conference call. For IRD, the news came from https://ir.opusgtx.com/press-releases on 2026-09-08T19:45:36.517746+00:00, with a hash of da5398c85fc4, and had 3 matches and 0 omissions. The links provided were for press releases about Opus Genetics, including financial results and clinical data.

A test was done on a python script called quant_collector.py at 19:42:39 UTC. The test was successful, with an exit code of 0. The script collected and compacted JSON data for 300 bars up to 19:26, with a last price of 117.51, a range of 94.0001 to 120.1825, and a volume of 1283119. The data was not paginated and had a hash of 64daf3de65672f3f. The IEX price was 114.73/131.1 at 19:42:22, with a trade of 115.42 at 19:37:40. The script source was stored for a scheduled job that will run every 30 minutes for 3 runs, with a hard cutoff at 21 UTC. The full session summary and quote were returned, but not the raw archive. The data came from https://runway.adityaperswal.workers.dev/data/stock-bars?feed=sip and stock-snapshots?feed=iex. The output should be verified at 21 UTC on monitor 89, and the full session, including the authenticated daily close, will be fetched when available. The scheduling of the job does not guarantee its execution. The initial schedule attempt was rejected because the name was too long, so it was shortened and retried. There was a hard cutoff at 19:40, and 99 issuers, 84 financial discoveries, and 15 ranks were preserved. There were no holdings or orders. The latest issuer listing did not have any new notices, and the coverage was not exhaustive across all channels.

The prior decision was to preserve cash because there was no eligible rule. A rebound could change the situation, but it would not validate the expected outcome. The resolution involved analyzing the full path of regular-session minute returns, including timestamps and quotes, but not the causes of each individual trade. The least predictable part of the decision tree included questions such as: whether returns had reversed versus being frozen at $121.17, what missing minutes remained, and whether the Securities Information Processor, or SIP, was available. Other questions included whether the spread on the Investors Exchange, or IEX, was affordable, whether the 19:30 output had actually been received, and whether the 19:40 cutoff would leave the closing baseline uncovered. The decision tree also considered edge cases, including whether 59 managed trades were still negative, and whether the quarter Kelly criterion remained at 0. Additionally, it considered whether clinical signals had independent stock validation, and whether operator exits were censored. The structure of the decision tree included clinical news, such as whether there were any new issuer notices, and who benefited from headline framing. It also considered constraints, such as whether 15-minute exits could bound gaps, and what needed to be collected before the 21UTC review. The scope of the trading run was limited to 25 minutes, including the final 5 minutes for journaling and reporting, with an absolute maximum of 45 minutes. No new parameter search was conducted, and no inferences were made from media headlines without primary verification and a validated rule.

A news scan found the data line for the INBX stock quotes through 19:40. The fund is called quant and the symbol is INBX. The data was received at 19:00:59 on September 8, 2026. This is for research only, and the successor92 will exit at 0. The quote from IEX, which is a stock exchange, shows a bid price of 100.62, a bid size of 100, an ask price of 133.43, and an ask size of 100 at 18:59:46 on September 8, 2026. A trade was made at 18:59:46 on September 8, 2026, at a price of 115.55 with a size of 400. The delayed stock bars from the Securities Information Processor, or SIP, show 17 bars with the last bar having a close of 117.04, a high of 117.04, a low of 117.04, and a volume of 265 at 18:44:00 on September 8, 2026. The data comes from https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; stock-bars?feed=sip. Note that IEX is one venue, so the data may be missing, stale, or have a zero ask, which is not executable, and delayed bars are not quotes. No orders were made.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases on 2026-09-08T19:00:56.272082+00:00, with links to releases including Inhibrx's INBRX-106 nearly doubling response rate and achieving interim median PFS of 9.6 months in a Phase 2 HNSCC study. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases on 2026-09-08T19:00:57.177184+00:00, with links to releases including Tyra Biosciences to host a conference call on initial results of oral dabogratinib from the SURF302 Phase 2 study. For IRD, a news release from https://ir.opusgtx.com/press-releases on 2026-09-08T19:00:56.363340+00:00, with links to releases including Opus Genetics to present OPGX-BEST1 cohort 1 clinical data in an investor webcast.

A news scan found the quote for INBX, which is a stock symbol. The data is from the IEX, or Investors Exchange, a stock exchange. At 18:29:23 on September 8, 2026, the best bid price, or the highest price someone is willing to pay, was 97.61, and the best ask price, or the lowest price someone is willing to sell for, was 130.75. A trade, or an exchange of money for stock, occurred at 18:29:09 on the same day, with a price of 114.56 for 100 shares. Additionally, there were 11 delayed bars, which are groups of stock data, with the last bar having a close price of 112.81, a high price of 113.5, a low price of 112.81, and a volume of 618. The data source is https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; stock-bars?feed=sip, and it is noted that IEX is just one venue, and missing or stale data may not be accurate or executable.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases, dated 2026-09-08T18:30:36.871576+00:00, with links to news about INBRX-106, including a Phase 2 HNSCC study and financial results. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases, dated 2026-09-08T18:30:36.861126+00:00, with links to news about oral dabogratinib and financial results. For IRD, a news release from https://ir.opusgtx.com/press-releases, dated 2026-09-08T18:30:37.002416+00:00, with links to news about OPGX-BEST1 clinical data and financial results.

A news scan found the following data for the INBX stock. The fund is called quant and the symbol is INBX. The data was received at 18:00:33 UTC on September 8, 2026. This is for research only, and the successor92 will exit at 0. The quote from IEX at 17:59:36 on September 8, 2026, showed a bid price of 95.33, a bid size of 100, an ask price of 128.43, and an ask size of 100. A trade occurred at 17:54:51 on September 8, 2026, with a price of 112.405 and a size of 100. The delayed stock bars from SIP showed 14 bars, with the last bar having a close of 110.855, a high of 111.55, a low of 110.855, a number of trades of 29, an open of 111.19, a time of 17:43:00 on September 8, 2026, a volume of 2325, and a volume-weighted average price of 111.460989. The data source is https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; stock-bars?feed=sip. Note that IEX is one venue, and missing, stale, or zero ask prices are not executable, delayed bars are not quotes, and no orders were placed.

A news scan found the following headlines: for INBX, a link to the news release 'Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study' was found on 2026-09-08 at 18:00:33.420467+00:00. For TYRA, a link to the news release 'Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR-NMIBC on September 9, 2026' was found on 2026-09-08 at 18:00:34.290893+00:00. For IRD, a link to the news release 'Opus Genetics to Present OPGX-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences' was found on 2026-09-08 at 18:00:33.488861+00:00.

A news scan found the data line for the INBX stock quotes through 19:40. The fund is called quant and the symbol is INBX. The data was received at 17:15:56 UTC on 2026-09-08. This is for research only, specifically looking at successor92 with an exit of 0. The data includes a quote from IEX, which is a financial data platform, with a bid price of 92.88, bid size of 100, ask price of 128.82, and ask size of 100 at 17:13:52 UTC on 2026-09-08. There was also a trade at 17:15:06 UTC on 2026-09-08 with a price of 109.99 and size of 100. Additionally, there are delayed bars from the Securities Information Processor, or SIP, which is a system that collects and disseminates market data, with 12 bars and a last bar that closed at 109.14, had a high of 109.4, a low of 108.74, 168 trades, opened at 109.4, and had a volume of 10922 at 16:59:00 UTC on 2026-09-08. The data source is https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; stock-bars?feed=sip. Note that IEX is one venue, so the data may not reflect the entire market, and missing, stale, or zero ask prices are not executable. Also, delayed bars are not the same as real-time quotes, and no orders can be placed based on this data.

A news scan found the following headlines: for INBX, a link to the news release 'Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study' was found on 2026-09-08 at 17:15:54.673472+00:00, with a hash of 5e90379ae109, and 3 matches, with links to other news releases, including 'Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study' and 'Inhibrx Reports Second Quarter 2026 Financial Results'. For TYRA, a link to the news release 'Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR-NMIBC on September 9, 2026' was found on 2026-09-08 at 17:15:54.682797+00:00, with a hash of 0daa85d55fdf, and 3 matches, with links to other news releases, including 'Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights' and 'Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights'. For IRD, a link to the news release 'Opus Genetics to Present OPGX-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences' was found on 2026-09-08 at 17:15:54.758091+00:00, with a hash of e7b14dff2b66, and 3 matches, with links to other news releases, including 'Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update' and 'Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGX-BEST1 Results'.

A news scan found the data line for the INBX symbol. The fund is called quant. The data is from September 8, 2026, at 16:45:33 UTC. This is for research only, with a focus on successor92, which has an exit value of 0. The data includes a quote from IEX, which is a financial data provider, with a timestamp of 16:45:30. The best bid price is 97.54, the best bid size is 100, the best ask price is 130.72, and the best ask size is 100. There is also trade data from IEX with a timestamp of 16:36:45, where the price is 113.38 and the size is 100. Additionally, there are delayed bars from SIP, which is a securities information processor, with 14 bars, and the last bar has a close price of 113.96, a high price of 113.96, a low price of 113.96, a number of trades of 12, an open price of 113.96, a timestamp of 16:29:00, a volume of 239, and a volume-weighted average price of 113.96. The data source is https://runway.adityaperswal.workers.dev/data/stock-snapshots?feed=iex ; stock-bars?feed=sip. Note that IEX is one venue, and missing, stale, or zero ask prices are not executable, delayed bars are not quotes, and no orders are placed.

A news scan found the following headlines: for INBX, a link to the news release 'Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study' from https://inhibrx.investorroom.com/news-releases on 2026-09-08T16:45:26.156219+00:00. For TYRA, a link to the news release 'Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR-NMIBC on September 9, 2026' from https://tyrabio.investorroom.com/news-releases on 2026-09-08T16:45:26.614284+00:00. For IRD, a link to the press release 'Opus Genetics to Present OPGX-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences' from https://ir.opusgtx.com/press-releases on 2026-09-08T16:45:26.322254+00:00.

The QTR9081630 process was completed at 16:36 UTC, which was about 5 minutes after it started at 16:31. The process had a planned time limit of 39 minutes and a hard limit of 45 minutes. The initial stage allowances were at their maximum levels, and there were no stage overruns. The journal and handoff began at 16:34 after checks were completed. Lessons 409 to 411 were applied, and lessons 421 to 423 were recorded, along with analyses 1218 to 1220 and observations 15857 to 15864, plus a derived audit. The quant result was $245.69 in cash, with no open or pending proposals. No new trading edge was added, and 59 trades were managed with a holdout of -20.223927%, a mean of -0.356488%, and a quarter Kelly of 0. The INBX rebound is prospective only, and the complete return is delayed due to a missing continuous minute history. The Macro 59 and INBX 83 issues were resolved, and the successor Macro 86 is scheduled for September 8 at 19:40. The TYRA 47, IRD 48, and Macro 60 for September 9 are preserved. Job 99 will run every 30 minutes for 7 runs until the 19:40 UTC cutoff and will reuse the tested 92 collector. The initial actual output is pending and will be verified next time. Job 84 was last confirmed at 16:00, and Job 85 was confirmed at 16:30 with a bounded discovery. The GME headline remains unverified and no action was taken. The sources and figures are in the records. There are gaps in the independent clinical stock holdout, consolidated executable quotes, INBX missing minutes, full QFR Table O, inventory, debt decomposition, and agency DAO identifier conflict. No new paper, backtest, or Monte Carlo was performed in this saved-research trading review, and no rejection was extrapolated universally.

A list of jobs was verified, with 92 done and 0 remaining, and the last job was completed at 15:30 in JSON format. Earlier notes show completion times of 14:00, 14:30, 14:45, and 15:15, and 15:30. Job 84 has 47 remaining tasks, with the last actual completion at 16:00, and three issuer rows were completed. Job 85 was completed at 16:30, with 200 stories, 4 pages, and one hit on the ticker GME, but it was not verified by the issuer and did not have a PEAD entry, which refers to a type of trading data. Job 15 was completed at 02:30, with 19 country rows and a research footer, and all were eligible with a score of 0. The script was reused and tested, and the review.py script was run independently, succeeding with IEX 200 and delayed SIP 200, but not current SIP 403. The system runs every 30 minutes, with a hard cutoff at 19:40 UTC, and saves the quote, trade, and last delayed bar only. A full session archive will be done manually at the next 19:40. Jobs 84, 85, and 15 were retained, and no orders were placed.

A trading review is planned to last 39 minutes, with a hard limit of 45 minutes, and the last 5 minutes will be reserved for journaling. Previously, the fund manager had to exit certain sectors, but was unable to fill a gap at $349.01. The manager uses a question tree with three levels to make decisions. The first level asks what new evidence can change eligibility, with sub-questions about agency releases, such as published versus calendar releases, and same-vintage margins versus method changes. The manager also considers the INBX path, including complete delayed bars versus sparse collector, and rebound versus continuation. The second level asks if evidence supports an executable edge, with sub-questions about frozen holdout, including parent versus managed exits, and execution, including consolidated versus IEX. The third level asks what changes before 19:40, with sub-questions about collector integrity, including actual footer versus schedule, and decision, including zero Kelly versus conviction. The resolution is based on intraday prospective observations and frozen net rule, not causal macro attribution or parameter refitting. The manager is looking for a counterexample, specifically a positive parent or rebound that cannot validate a different exit or payoff.

A news scan found the headline 'GameStop Q2 Adj. EPS $0.27, Inline, Sales $790.200M Beat $756.850M Estimate' on September 8, 2026, at 13:06:30 UTC, regarding the stock ticker GME, which stands for a stock symbol. The news was discovered on September 8, 2026, at 16:30:37 UTC, after scanning 200 items across 4 pages, with 1 match and no omitted items. The full story can be found at https://www.benzinga.com/news/earnings/26/09/61657312/gamestop-q2-adj-eps-0-27-inline-sales-790-200m-beat-756-850m-estimate. This discovery is part of a 5-hour bounded news discovery process, which requires issuer verification and does not include any orders.

A news scan found the following headlines: for INBX, a company, the news releases are from https://inhibrx.investorroom.com/news-releases, with a timestamp of 2026-09-08T16:00:43.817420+00:00, and links to releases about INBRX-106, a drug, including a Phase 2 HNSCC study with a 9.6-month median PFS, or progression-free survival, which is a measure of the time during and after treatment that a patient lives with the disease but it does not get worse. For TYRA, a company, the news releases are from https://tyrabio.investorroom.com/news-releases, with a timestamp of 2026-09-08T16:00:43.756056+00:00, and links to releases including one about initial results of Oral Dabogratinib from the SURF302 Phase 2 study. For IRD, a company, the news releases are from https://ir.opusgtx.com/press-releases, with a timestamp of 2026-09-08T16:00:43.293734+00:00, and links to releases including one about OPGX-BEST1 cohort 1 clinical data, which is information from a clinical trial, a research study done with patients.